Dr. Shauna Springer | Source | Licensed psychologist, trauma & PTSD expert, Chief Psychologist at Stella

DS

Dr. Shauna Springer

Licensed psychologist, trauma & PTSD expert, Chief Psychologist at Stella
On the record
Represented by:
Share profile 
Link:
Bio
Edit

Shauna 'Doc' Springer is a co-founder and the Chief Psychologist for Stella, a leading, trusted authority on innovative trauma treatments. Dr. Springer is responsible for developing Stella's trauma informed approach to care across its international network of more than 30 clinics. She leads training and public speaking engagements for Stella and is the host of the podcast "The Story of Our Trauma." She is a best-selling author of three books on trauma and is widely considered to be one of the world's leading experts on psychological trauma, military transition, suicide prevention, and close relationships.

Employment
Sign up to view all
  • Stella
    Licensed psychologist, trauma & PTSD expert, Chief Psychologist
Story Ideas
Sign up to view all
  • Rethinking Holiday Gift Giving: Reducing Stress and Anxiety
    Dr. Springer highlights how gift giving can trigger anxiety, with concerns over social status and identity. She suggests alternatives like creating shared photo albums, attending classes, or planning memorable outings to foster connection. Moving away from materialism can reduce stress and enhance relationships. For deeper anxiety issues, Stella offers innovative treatments. Visit www.stellacenter.com for more information.
  • FDA Rejects MDMA Therapy for PTSD: Expert Calls for Responsible Innovation
    Dr. Springer states, "MDMA and other psychedelics hold significant promise for treating PTSD." She emphasizes the need for "responsible innovation," ensuring treatments are administered with medical monitoring and essential talk therapy. "We must innovate as if lives depend on it—because they do," she concludes.
  • FDA's MDMA Decision: A Call for Responsible Innovation
    Dr. Springer emphasizes, "MDMA offers a promising path to healing for PTSD sufferers." She advocates for "responsible innovation," stressing the need for safety protocols, appropriate staffing, and integrated therapy. Approval should focus on how MDMA is administered, ensuring all safety concerns are addressed.